切换至 "中华医学电子期刊资源库"
高级检索
中华危重症医学杂志(电子版)

中华危重症医学杂志(电子版) ›› 2017, Vol. 10 ›› Issue (02) : 92 -97. doi: 10.3877/cma.j.issn.1674-6880.2017.02.005

所属专题： 文献；

论著

脓毒性休克患者左心室舒张功能不全相关因素分析及其预后影响
呼邦传,1, 王宇佳1, 葛伟东2, 李锋之2, 孙仁华1   
  1. 1. 310014　杭州，浙江省人民医院重症医学科
    2. 310014　杭州，浙江省人民医院超声科
  • 收稿日期:2016-10-26 出版日期:2017-04-01
  • 通信作者: 呼邦传
  • 基金资助:
    浙江省公益性技术应用研究项目(2014C37023); 浙江省自然科学基金项目(LY17H15000); 浙江省医药卫生平台骨干项目(2013RCB001)

Analysis on correlation factors of left ventricular diastolic dysfunction and its association with mortality in the patients with septic shock

Bangchuan Hu,1, Yujia Wang1, Weidong Ge2, Fengzhi Li2, Renhua Sun1   

  1. 1. Department of Intensive Care Unit, Zhejiang Provincial People’s Hospital, Hangzhou 310014, China
    2. Department of Ultrasonography, Zhejiang Provincial People’s Hospital, Hangzhou 310014, China
  • Received:2016-10-26 Published:2017-04-01
  • Corresponding author: Bangchuan Hu
  • About author:
    Corresponding author: Hu Bangchuan, Email: hubangchuanicu@163.com
全文 ( 0 ) 下载PDF ( 1 ) 导出引用
引用本文：

呼邦传, 王宇佳, 葛伟东, 李锋之, 孙仁华. 脓毒性休克患者左心室舒张功能不全相关因素分析及其预后影响[J/OL]. 中华危重症医学杂志(电子版), 2017, 10(02): 92-97.

Bangchuan Hu, Yujia Wang, Weidong Ge, Fengzhi Li, Renhua Sun. Analysis on correlation factors of left ventricular diastolic dysfunction and its association with mortality in the patients with septic shock[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2017, 10(02): 92-97.

目的

探讨影响脓毒性休克患者左心室舒张功能不全（LVDD）的相关因素及其对临床预后影响。

方法

选取2014年6月至2015年12月浙江省人民医院ICU收治的127例脓毒性休克患者，按照舒张功能分为LVDD组（49例）和对照组（78例），对照组为左心室舒张功能正常患者。对两组患者的一般资料进行比较。于入ICU 24 h内行超声心动图检查，结合二尖瓣环舒张早期运动速度峰值（E’）和二尖瓣舒张早期血流速峰值/二尖瓣环舒张早期运动速度峰值比率（E/E’）作为评价脓毒性休克患者LVDD的指标。运用Pearson简单相关分析探讨影响脓毒性休克患者LVDD的相关因素，采用多元Logistic回归分析脓毒性休克患者死亡的危险因素。

结果

两组患者在年龄[（63 ± 14）岁vs.（58 ± 18）岁]、入ICU时收缩压[（90 ± 18）mmHg vs.（99 ± 18）mmHg]、冠状动脉粥样硬化性心脏病（CHD）（15/49 vs. 12/78）、血肌酐[（188 ± 96）μmol/L vs.（116 ± 92）μmol/L]、急性病生理学与长期健康状况评价（APACHE）Ⅱ评分[（21 ± 5）分vs.（17 ± 6）分]、血浆脑利钠肽（BNP）[（178 ± 84）pg/mL vs.（355 ± 128）pg/mL]、左室收缩末期内径（LVESD）[（34 ± 8）mm vs.（31 ± 5）mm]、室间隔厚度（IVST）[（10.1 ± 1.9）mm vs.（9.4 ± 1.4）mm]、左室后壁厚度（PWT）[（10.2 ± 1.5）mm vs.（9.6 ± 1.2）mm]、左室侧壁二尖瓣环收缩期运动速度峰值（S’）[（9.0 ± 3.0）cm/s vs.（11.4 ± 3.6）cm/s]、E’[（7.3 ± 2.3）cm/s vs.（12.3 ± 3.6）cm/s]及E/E’[（11.6 ± 4.0）vs.（6.8 ± 2.6）]方面比较，差异均有统计学意义（P均< 0.05）。相关分析显示：年龄、高血压、CHD、血浆BNP和APACHEⅡ评分与E/E’呈正相关（r = 0.302、0.289、0.277、0.418、0.290，P均< 0.05）；而入ICU收缩压和左室射血分数（LVEF）与E/E’呈负相关（r = -0.239、-0.284，P均< 0.05）。多元Logistic回归分析统计结果显示：年龄[OR = 1.040，95%CI（1.020，1.071）]、血乳酸[OR = 1.492，95%CI（1.176，1.732）]、血浆BNP [OR = 2.051，95% CI（1.232，2.964）]、E/E’ [OR = 1.362，95% CI（1.122，1.534）]和APACHEⅡ评分[OR = 2.370，95%CI（1.131，3.674）]是预测脓毒性休克患者死亡的独立危险因素（P均< 0.05）。

结论

年龄、入ICU收缩压、高血压、冠状动脉粥样硬化性心脏病、血浆BNP、APACHEⅡ评分和LVEF与脓毒性休克患者LVDD存在相关；而年龄、血乳酸、血浆BNP、E/E’和APACHEⅡ评分是脓毒性休克患者死亡的独立危险因素。

关键词: 脓毒性休克, 左心室舒张功能不全, B型脑利钠肽, 预后
Objective

To study the determinants of left ventricular diastolic dysfunction (LVDD) and investigate its association with mortality in patients with septic shock.

Methods

Totally 127 patients with septic shock in Zhejiang Provincial People’s Hospital recruited from June 2014 to December 2015 were divided into the LVDD group (49 cases) and control group as patients with normal left ventricular diastolic function (78 cases). General data of the two groups were compared. According to diastolic function underwent trans-thoracic echocardiography examination within 24 h after admission to ICU, LVDD was assessed as the conbination early diastolic mitral annulus velocity (E’) with the ratio of early diastolic mitral inflow velocity to early diastolic mitral annulus velocity (E/E’). The related factors of LVDD in patients with septic shock were analyzed by Pearson simple correlation, and the risk factors associated with mortality in patients with septic shock were evaluated by multivariate Logistic regression.

Results

Compared with the normal group, the age [(63 ± 14) years vs. (58 ± 18) years], systolic blood pressure admitted to ICU [(90 ± 18) mmHg vs. (99 ± 18) mmHg], coronary atherosclerotic heart disease (CHD) (15/49 vs. 12/78), serum creatinine [(188 ± 96) μmol/L vs. (116 ± 92) μmol/L], acute physiology and chronic health evaluation (APACHE) Ⅱ scores [(21 ± 5) vs. (17 ± 6)], plasma brain natriuretic peptide (BNP) [(178 ± 84) pg/mL vs. (355 ± 128) pg/mL], left ventricular end systolic diamete (LVESD) [(34 ± 8) mm vs. (31 ± 5) mm], interventricular septal thickness (IVST) [(10.1 ± 1.9) mm vs. (9.4 ± 1.4) mm], left ventricular posterior wall thickness (PWT) [(10.2 ± 1.5) mm vs. (9.6 ± 1.2) mm], mitral annular systolic velocity peak (S’) [(9.0 ± 3.0) cm/s vs. (11.4 ± 3.6) cm/s], E’[(7.3 ± 2.3) cm/s vs. (12.3 ± 3.6) cm/s] and E/E’[(11.6 ± 4.0) vs. (6.8 ± 2.6)] of these two groups were significantly different (all P < 0.05). Correlation analysis showed that E/E’ had a positive correlation with age, hypertension, CHD, plasma BNP and APACHEⅡ score (r = 0.302, 0.289, 0.277, 0.418, 0.290; all P < 0.05). However, the systolic blood pressure admitted to ICU and left ventricular eject fraction (LVEF) had negative correlations with those parameters (r = -0.239, -0.284; all P < 0.05). Multivariate Logistic regression analysis found that age [OR = 1.040, 95% CI (1.020, 1.071)], blood lactic acid [OR = 1.492, 95% CI (1.176, 1.732)], plasma BNP [OR = 2.051, 95% CI (1.232, 2.964)], E/E’ [OR = 1.362, 95% CI (1.122, 1.534)] and APACHE Ⅱ score [OR = 2.370, 95% CI (1.131, 3.674)] were the independent risk factors associated with mortality in patients with septic shock (all P < 0.05).

Conclusions

Age, systolic blood pressure admitted to ICU, hypertension, CHD, plasma BNP, APACHEⅡ score and LVEF were significantly related to LVDD. However, age, blood lactic acid, plasma BNP, E/E’and APACHE Ⅱ score were the independent risk factors associated with mortality in patients with septic shock.

Key words: Septic shock, Left ventricular diastolic dysfunction, B-type brain natriuretic peptide, Prognosis
表1 两组脓毒性休克患者一般资料比较（ ± s）
组别 例数 入ICU收缩压（mmHg） 入ICU舒张压（mmHg） 血糖（mmol/L） 白蛋白（g/L） 血乳酸（mmol/L）
LVDD组 49 90 ± 18 57 ± 16 9.2 ± 1.6 32 ± 4 2.9 ± 1.3
对照组 78 99 ± 18 60 ± 14 9.0 ± 1.4 32 ± 6 2.8 ± 1.8
t/χ2值 ? 2.633 1.269 0.441 0.132 0.247
P值 ? 0.024 0.197 0.632 0.922 0.787
组别 例数 血肌酐（μmol/L） APACHEⅡ评分（分） 肌钙蛋白I（ng/mL） 血浆BNP（pg/mL） 血管活性药物使用（例，%）
LVDD组 49 188 ± 96 21 ± 5 0.7 ± 1.6 355 ± 128 45（91.8%）
对照组 78 116 ± 92 17 ± 6 0.5 ± 1.6 178 ± 84 69（88.5%）
t/χ2值 ? 3.819 4.558 0.653 5.848 0.371
P值 ? < 0.001 < 0.001 0.523 < 0.001 0.542
表2 两组脓毒性休克患者心脏超声资料比较（ ± s）
组别 例数 LVEDD（mm） LVESD（mm） IVST（mm） PWT（mm） LVEF（分） E（m/s）
LVDD组 49 50 ± 7 34 ± 8 10.1 ± 1.9 10.2 ± 1.5 53 ± 14 0.85 ± 0.30
对照组 78 49 ± 6 31 ± 5 9.4 ± 1.4 9.6 ± 1.2 55 ± 10 0.84 ± 0.22
t/χ2值 ? 1.123 2.459 2.782 2.374 0.830 0.292
P值 ? 0.276 0.032 0.025 0.037 0.326 0.734
组别 例数 A（m/s） E/A DT（m/s） S’（cm/s） E’（cm/s） E/E’
LVDD组 49 0.84 ± 0.32 1.1 ± 0.6 134 ± 57 9.0 ± 3.0 7.3 ± 2.3 11.6 ± 4.0
对照组 78 0.77 ± 0.21 1.1 ± 0.4 146 ± 54 11.4 ± 3.6 12.3 ± 3.6 6.8 ± 2.6
t/χ2值 ? 1.353 0.618 0.865 3.948 6.786 5.320
P值 ? 0.201 0.553 0.302 < 0.001 < 0.001 < 0.001
表3 Logistic回归评价脓毒性休克死亡危险因素
指标 回归系数 标准误 OR值 95%CI Wald值 P值
年龄（岁） 0.041 0.030 1.040 1.020 ~ 1.071 5.631 0.022
血乳酸（mmol/L） 0.202 0.123 1.492 1.176 ~ 1.732 4.894 0.032
血浆BNP（ng/L） 0.289 0.103 2.051 1.232 ~ 2.964 8.569 0.007
E/E’ 0.151 0.053 1.362 1.122 ~ 1.534 3.980 0.043
APACHEⅡ评分（分） 0.318 0.116 2.370 1.131 ~ 3.674 10.52 0.001
1
Pulido JN, Afessa B, Masaki M, et al. Clinical spectrum, frequency, and significance of myocardial dysfunction in severe sepsis and septic shock[J]. Mayo Clin Proc, 2012, 87 (7): 620-628.
2
赖志珍，孟建标，胡马洪，等. 左西孟旦对脓毒性休克患者血流动力学及心肌损伤标志物的影响[J/CD]. 中华危重症医学杂志（电子版），2016，9(3):163-168.
3
Acil T, Wichter T, Stypmann J, et al. Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure[J]. Int J Cardiol, 2005, 103 (2): 175-181.
4
Lee CH, Hung KC, Chang SH, et al. Reversible left ventricular diastolic dysfunction on Doppler tissue imaging predicts a more favorable prognosis in chronic heart failure[J]. Circ J, 2012, 76 (5): 1145-1150.
5
Sturgess DJ, Marwick TH, Joyce C, et al. Prediction of hospital outcome in septic shock: a prospective comparison of tissue Doppler and cardiac biomarkers[J]. Crit Care, 2010, 14 (2): R44.
6
Landesberg G, Gilon D, Meroz Y, et al. Diastolic dysfunction and mortality in severe sepsis and septic shock[J]. Eur Heart J, 2012, 33 (7): 895-903.
7
Brown SM, Pittman JE, Hirshberg EL, et al. Diastolic dysfunction and mortality in early severe sepsis and septic shock: a prospective, observational echocardiography study[J]. Crit Ultrasound J, 2012, 4 (1): 8.
8
Lim HS, Kang SJ, Choi JH, et al. Is E/E' reliable in patients with regional wall motion abnormalities to estimate left ventricular filling pressure[J]. Int J Cardiovasc Imaging, 2009, 25 (1): 33-39.
9
Grewal J, McKelvie R, Lonn E, et al. BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction[J]. Eur J Heart Fail, 2008, 10 (3): 252-259.
10
AlJaroudi WA, Thomas JD, Rodriguez LL, et al. Prognostic value of diastolic dysfunction: state of the art review[J]. Cardiol Rev, 2014, 22 (2): 79-90.
11
Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012[J]. Crit Care Med, 2013, 41 (2): 580-637.
12
Paulus WJ, Tschope C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heartfailure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology[J]. Eur Heart J, 2007, 28 (20): 2539-2550.
13
Borlaug BA, Lam CS, Roger VL, et al. Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction[J]. J Am Coll Cardiol, 2009, 54 (5): 410-418.
14
Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study[J]. N Engl J Med, 2006, 355 (3): 260-269.
15
Dokainish H, Zoghbi WA, Lakkis NM, et al. Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters[J]. Circulation. 2004, 109 (20): 2432-2439.
16
Tsang TS, Barnes ME, Gersh BJ, et al. Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden[J]. Am J Cardiol, 2002, 90 (12): 1284-1289.
17
Pritchett AM, Mahoney DW, Jacobsen SJ, et al. Diastolic dysfunction and left atrial volume: a population-based study[J]. J Am Coll Cardiol, 2005, 45 (1): 87-92.
18
Noh JH, Doh JH, Lee SY, et al. Risk factors associated with left ventricular diastolic dysfunction in type 2 diabetic patients without hypertension[J]. Korean Diabetes J, 2010, 34 (1): 40-46.
19
AlJaroudi W, Alraies MC, Halley CM, et al. Incremental prognostic value of isolated diastolic dysfunction in healthy patients: beyond framingham risk score[J]. Eur Heart J, 2012, 33 (suppl 1): 339-653.
20
Mak GS, DeMaria A, Clopton P, et al. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings[J]. Am Heart J, 2004, 148 (5): 895-902.
21
Grewal J, McKelvie RS, Persson H, et al. Usefulness of N-terminal pro-brain natriuretic peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction[J]. Am J Cardiol, 2008, 102 (6): 733-737.
22
Ikonomidis I, Nikolaou M, Dimopoulou I, et al. Association of left ventricular diastolic dysfunction with elevated NT-pro-BNP in general intensive care unit patients with preserved ejection fraction: a complementary role of tissue Doppler imaging parameters and NT-pro-BNP levels for adverse outcome[J]. Shock, 2010, 33 (2): 141-148.
23
Antonucci E, Fiaccadori E, Donadello K, et al. Myocardial depression in sepsis: from pathogenesis to clinical manifestations and treatment[J]. J Crit Care, 2014, 29 (4): 500-511.
24
Sanfilippo F, Corredor C, Fletcher N, et al. Diastolic dysfunction and mortality in septic patients:a systematic review and meta-analysis[J]. Intensive Care Med, 2015, 41 (6): 1004-1013.
[1] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[2] 高杰红, 黎平平, 齐婧, 代引海. ETFA和CD34在乳腺癌中的表达及与临床病理参数和预后的关系研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 64-67.
[3] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[4] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[5] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[6] 付成旺, 杨大刚, 王榕, 李福堂. 营养与炎症指标在可切除胰腺癌中的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 704-708.
[7] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[8] 李伟, 宋子健, 赖衍成, 周睿, 吴涵, 邓龙昕, 陈锐. 人工智能应用于前列腺癌患者预后预测的研究现状及展望[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 541-546.
[9] 陈樽, 王平, 金华, 周美玲, 李青青, 黄永刚. 肌肉减少症预测结直肠癌术后切口疝发生的应用研究[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 639-644.
[10] 关小玲, 周文营, 陈洪平. PTAAR在乙肝相关慢加急性肝衰竭患者短期预后中的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 841-845.
[11] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[12] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[13] 董佳, 王坤, 张莉. 预后营养指数结合免疫球蛋白、血糖及甲胎蛋白对HBV 相关慢加急性肝衰竭患者治疗后预后不良的预测价值[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(06): 555-559.
[14] 王景明, 王磊, 许小多, 邢文强, 张兆岩, 黄伟敏. 腰椎椎旁肌的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 846-852.
[15] 郭曌蓉, 王歆光, 刘毅强, 何英剑, 王立泽, 杨飏, 汪星, 曹威, 谷重山, 范铁, 李金锋, 范照青. 不同亚型乳腺叶状肿瘤的临床病理特征及预后危险因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 524-532.
阅读次数
全文
1
HTML PDF
最新录用 在线预览 正式出版 最新录用 在线预览 正式出版
0 0 0 0 0 1

  来源 其他网站
  次数 1
  比例 100%

摘要
25
最新录用 在线预览 正式出版
0 0 25
  来源 本网站 其他网站
  次数 10 15
  比例 40% 60%

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号